These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 23954466)

  • 1. A novel natural Nrf2 activator with PPARγ-agonist (monascin) attenuates the toxicity of methylglyoxal and hyperglycemia.
    Hsu WH; Lee BH; Chang YY; Hsu YW; Pan TM
    Toxicol Appl Pharmacol; 2013 Nov; 272(3):842-51. PubMed ID: 23954466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monascin and AITC attenuate methylglyoxal-induced PPARγ phosphorylation and degradation through inhibition of the oxidative stress/PKC pathway depending on Nrf2 activation.
    Hsu WH; Lee BH; Li CH; Hsu YW; Pan TM
    J Agric Food Chem; 2013 Jun; 61(25):5996-6006. PubMed ID: 23731245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel PPARgamma agonist monascin's potential application in diabetes prevention.
    Hsu WH; Pan TM
    Food Funct; 2014 Jul; 5(7):1334-40. PubMed ID: 24752777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ankaflavin: a natural novel PPARγ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo.
    Lee BH; Hsu WH; Chang YY; Kuo HF; Hsu YW; Pan TM
    Free Radic Biol Med; 2012 Dec; 53(11):2008-16. PubMed ID: 23022408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of monascin on anti-inflammation mediated by Nrf2 activation in advanced glycation end product-treated THP-1 monocytes and methylglyoxal-treated wistar rats.
    Lee BH; Hsu WH; Huang T; Chang YY; Hsu YW; Pan TM
    J Agric Food Chem; 2013 Feb; 61(6):1288-98. PubMed ID: 23331247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dimerumic acid attenuates receptor for advanced glycation endproducts signal to inhibit inflammation and diabetes mediated by Nrf2 activation and promotes methylglyoxal metabolism into d-lactic acid.
    Lee BH; Hsu WH; Hsu YW; Pan TM
    Free Radic Biol Med; 2013 Jul; 60():7-16. PubMed ID: 23434766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-γ activators monascin and rosiglitazone attenuate carboxymethyllysine-induced fibrosis in hepatic stellate cells through regulating the oxidative stress pathway but independent of the receptor for advanced glycation end products signaling.
    Hsu WH; Lee BH; Hsu YW; Pan TM
    J Agric Food Chem; 2013 Jul; 61(28):6873-9. PubMed ID: 23796251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scopoletin protects against methylglyoxal-induced hyperglycemia and insulin resistance mediated by suppression of advanced glycation endproducts (AGEs) generation and anti-glycation.
    Chang WC; Wu SC; Xu KD; Liao BC; Wu JF; Cheng AS
    Molecules; 2015 Feb; 20(2):2786-801. PubMed ID: 25671364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monascin attenuates oxidative stress-mediated lung inflammation via peroxisome proliferator-activated receptor-gamma (PPAR-γ) and nuclear factor-erythroid 2 related factor 2 (Nrf-2) modulation.
    Hsu WH; Lee BH; Pan TM
    J Agric Food Chem; 2014 Jun; 62(23):5337-44. PubMed ID: 24865672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monascin improves diabetes and dyslipidemia by regulating PPARγ and inhibiting lipogenesis in fructose-rich diet-induced C57BL/6 mice.
    Lee BH; Hsu WH; Huang T; Chang YY; Hsu YW; Pan TM
    Food Funct; 2013 Jun; 4(6):950-9. PubMed ID: 23673903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of monascin on hematoma clearance and edema after intracerebral hemorrhage in rats.
    Wang J; Wang G; Yi J; Xu Y; Duan S; Li T; Sun XG; Dong L
    Brain Res Bull; 2017 Sep; 134():24-29. PubMed ID: 28655601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma down-regulates receptor for advanced glycation end products and inhibits smooth muscle cell proliferation in a diabetic and nondiabetic rat carotid artery injury model.
    Wang K; Zhou Z; Zhang M; Fan L; Forudi F; Zhou X; Qu W; Lincoff AM; Schmidt AM; Topol EJ; Penn MS
    J Pharmacol Exp Ther; 2006 Apr; 317(1):37-43. PubMed ID: 16368901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol upregulates Nrf2 expression to attenuate methylglyoxal-induced insulin resistance in Hep G2 cells.
    Cheng AS; Cheng YH; Chiou CH; Chang TL
    J Agric Food Chem; 2012 Sep; 60(36):9180-7. PubMed ID: 22917016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monacolin K and monascin attenuated pancreas impairment and hyperglycemia induced by advanced glycation endproducts in BALB/c mice.
    Hsu WH; Lu SS; Lee BH; Hsu YW; Pan TM
    Food Funct; 2013 Dec; 4(12):1742-50. PubMed ID: 24154804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monascus-fermented yellow pigments monascin and ankaflavin showed antiobesity effect via the suppression of differentiation and lipogenesis in obese rats fed a high-fat diet.
    Lee CL; Wen JY; Hsu YW; Pan TM
    J Agric Food Chem; 2013 Feb; 61(7):1493-500. PubMed ID: 23360447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Monascus metabolite monascin against TNF-α-induced insulin resistance via suppressing PPAR-γ phosphorylation in C2C12 myotubes.
    Lee BH; Hsu WH; Liao TH; Pan TM
    Food Chem Toxicol; 2011 Oct; 49(10):2609-17. PubMed ID: 21777645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graptopetalum paraguayense and resveratrol ameliorates carboxymethyllysine (CML)-induced pancreas dysfunction and hyperglycemia.
    Lee BH; Lee CC; Cheng YH; Chang WC; Hsu WH; Wu SC
    Food Chem Toxicol; 2013 Dec; 62():492-8. PubMed ID: 24036142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor.
    Ihm SH; Chang K; Kim HY; Baek SH; Youn HJ; Seung KB; Kim JH
    Basic Res Cardiol; 2010 May; 105(3):399-407. PubMed ID: 19902320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention.
    Kim MK; Chae YN; Kim HS; Choi SH; Son MH; Kim SH; Kim JK; Moon HS; Park SK; Shin YA; Kim JG; Lee CH; Lim JI; Shin CY
    Arch Pharm Res; 2009 May; 32(5):721-7. PubMed ID: 19471887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARγ activation mitigates mechanical allodynia in paclitaxel-induced neuropathic pain via induction of Nrf2/HO-1 signaling pathway.
    Zhou YQ; Liu DQ; Chen SP; Chen N; Sun J; Wang XM; Li DY; Tian YK; Ye DW
    Biomed Pharmacother; 2020 Sep; 129():110356. PubMed ID: 32535388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.